Related Experiment Video
Updated: Sep 7, 2025
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Advances in Clinical Oncology Research on 99mTc-3PRGD2 SPECT Imaging
1Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
Abstract:
The integrin alpha(α)v beta(β)3 receptor is ubiquitous in malignant tumors and has a certain level of specificity for tumors. Technetium-99m hydrazinonicotinamide-dimeric cyclic arginyl-glycyl-aspartic acid peptide with three polyethylene glycol spacers (99mTc-3PRGD2) can bind specifically to the integrin αvβ3 receptor with high selectivity and strong affinity. Thus, it can specifically mark tumors and regions with angiogenesis for tumor detection and be used in single-photon emission computed tomography (SPECT) imaging. This modality has good application value for diagnosing and treating tumor lesions, such as those in the lung, breast, esophagus, head, and neck. This review provides an overview of the current clinical research progress of 99mTc-3PRGD2 SPECT imaging for tumor lesions, including for the diagnosis and differential diagnosis of tumors in different body parts, evaluation of related metastases, and evaluation of efficacy. In addition, the future clinical application prospects and possibilities of 99mTc-3PRGD2 SPECT imaging are further discussed.
Insights
Technetium-99m 3PRGD2 SPECT imaging targets the integrin αvβ3 receptor, enabling specific tumor detection and diagnosis. This method shows promise for various cancers, including lung, breast, and head/neck tumors.
Area of Science:
- Nuclear medicine
- Oncology
- Radiopharmaceutical imaging
Background:
- Integrin αvβ3 receptors are prevalent in malignant tumors, offering tumor-specific targeting.
- Technetium-99m 3PRGD2 (99mTc-3PRGD2) exhibits high affinity and selectivity for integrin αvβ3.
Purpose of the Study:
- To review the clinical progress of 99mTc-3PRGD2 SPECT imaging in tumor detection and diagnosis.
- To evaluate the application of 99mTc-3PRGD2 SPECT for diagnosing various cancers and assessing treatment efficacy.
Main Methods:
- 99mTc-3PRGD2 radiopharmaceutical for SPECT imaging.
- Clinical research review focusing on tumor lesion detection, differential diagnosis, metastasis evaluation, and efficacy assessment.
Main Results:
- 99mTc-3PRGD2 SPECT imaging demonstrates significant potential for tumor visualization and characterization.
- The modality is applicable to diverse tumor types, including lung, breast, esophagus, head, and neck cancers.
Conclusions:
- 99mTc-3PRGD2 SPECT imaging is a valuable tool for oncological diagnosis and treatment monitoring.
- Future applications may expand its role in personalized cancer management and therapy evaluation.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...